Regentis Biomaterials Cash Flow Statement (2024-2025) | RGNT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2024	Dec2025
Operating Activities
Gains from Investment Securities (Quarter)	79,290.00	965,000.00
Non-cash Items (Quarter)	550,000.00	741,294.00